Patient Guide: A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 30 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06902558
Status: 🟢 Enrolling Now
Condition: Autosomal Dominant Polycystic Kidney Disease
Phase: PHASE2

Where You Can Participate

This study is available at 30 locations across the country.

Top locations include:
  • • Garden Grove, California
  • • Huntington Park, California
  • • Los Angeles, California
  • • And 27 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD) - Join Clinical Trial NCTNCT06902558

How to Join This Clinical Trial - NCTNCT06902558

Learn how to participate in this PHASE2 trial studying an investigational therapy for Autosomal Dominant Polycystic Kidney Disease. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Autosomal Dominant Polycystic Kidney Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Autosomal Dominant Polycystic Kidney Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06902558 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 30 locations. Find a study site near you:

Clinical Research Site

Garden Grove, California 92844 - United States

Status: RECRUITING

Clinical Research Site

Huntington Park, California 90255 - United States

Status: RECRUITING

Clinical Research Site

Los Angeles, California 90022 - United States

Status: RECRUITING

Clinical Research Site

Orange, California 92868-3201 - United States

Status: RECRUITING

Clinical Research Site

Coral Gables, Florida 33134 - United States

Status: RECRUITING

Clinical Research Site

Inverness, Florida 34452-4717 - United States

Status: RECRUITING

Clinical Research Site

Jacksonville, Florida 32224 - United States

Status: RECRUITING

Clinical Research Site

Miami, Florida 33014 - United States

Status: RECRUITING

Clinical Research Site

Shelby, Michigan 48315 - United States

Status: RECRUITING

Clinical Research Site

Rochester, Minnesota 55905 - United States

Status: RECRUITING

And 20 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Autosomal Dominant Polycystic Kidney Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships